SMTL ID : 6nji.1 (1 other biounit)

Crystal Structure of the PDE4D Catalytic Domain and UCR2 Regulatory Helix with T-49

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.88, H.124, D.125, D.242 Ligands: MG.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.88, A:H.124, A:D.125, A:D.242, H2O.1

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 3 residues within 4Å: Chain A: H.124, D.125 Ligands: ZN.1 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.125, H2O.1, H2O.2, H2O.2, H2O.2

1 x KR4: 2-(4-{[4-(3-chlorophenyl)-6-ethyl-1,3,5-triazin-2-yl]amino}phenyl)ethan-1-ol(Non-covalent)

KR4.3: 13 residues within 4Å: Chain A: H.84, M.197, L.243, N.245, W.256, T.257, I.260, M.281, Q.293, F.296, F.357, I.358, T.361 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:N.245, A:I.260, A:F.296, A:F.296, A:F.357 Hydrogen bonds: A:Q.293 Water bridges: A:Y.83, A:Y.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gurney, M.E. et al., Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders. J.Med.Chem. (2019)

Release Date

2019-05-08

Peptides

cAMP-specific 3',5'-cyclic phosphodiesterase 4D: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP-specific 3',5'-cyclic phosphodiesterase 4D

Related Entries With Identical Sequence